Pitolisant

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 244 publications

Corrigendum to "Discovery of novel H3R antagonists with potent antiseizure activity and favorable pharmacokinetics via scaffold-hopping from pitolisant to rigid 4-phenylindoles" [Bioorg. Chem. 181 (2026) 110309].

Corrigendum to "Discovery of novel H3R antagonists with potent antiseizure activity and favorable pharmacokinetics via scaffold-hopping from pitolisant to rigid 4-phenylindoles" [Bioorg. Chem. 181 (2026) 110309].

Journal: Bioorganic chemistry

Published: August 17, 2026

Discovery of novel H3R antagonists with potent antiseizure activity and favorable pharmacokinetics via scaffold-hopping from pitolisant to rigid 4-phenylindoles.

Discovery of novel H3R antagonists with potent antiseizure activity and favorable pharmacokinetics via scaffold-hopping from pitolisant to rigid 4-phenylindoles.

Journal: Bioorganic chemistry

Published: June 11, 2026

Psychopharmacology of Eugeroics-The Whole Nine Yards!

Psychopharmacology of Eugeroics-The Whole Nine Yards!

Journal: Psychopharmacology bulletin

Published: June 10, 2026

Recent Advances and Emerging Pharmacotherapeutic Approaches for Central Hypersomnolence Disorders.

Recent Advances and Emerging Pharmacotherapeutic Approaches for Central Hypersomnolence Disorders.

Journal: Clinical pharmacology : advances and applications

Published: April 21, 2026

Current and Emerging Therapies for Pediatric Sleep Disorders: A Narrative Review.

Current and Emerging Therapies for Pediatric Sleep Disorders: A Narrative Review.

Journal: Neurology and therapy

Published: March 31, 2026

Design, synthesis and pharmacological evaluation of novel 2-aryloxazole-based H3 receptor antagonists as potent, antiseizure agents.

Design, synthesis and pharmacological evaluation of novel 2-aryloxazole-based H3 receptor antagonists as potent, antiseizure agents.

Journal: Molecular diversity

Published: March 29, 2026

Pharmacotherapy in obstructive sleep apnoea: a clinical guide.

Pharmacotherapy in obstructive sleep apnoea: a clinical guide.

Journal: Sleep & breathing = Schlaf & Atmung

Published: March 18, 2026

Histamine shapes the neurocomputational dynamics of human learning.

Histamine shapes the neurocomputational dynamics of human learning.

Journal: Nature communications

Published: March 17, 2026

Therapeutic potential of histamine N-methyltransferase inhibition for the treatment of hypersomnia

Therapeutic potential of histamine N-methyltransferase inhibition for the treatment of hypersomnia

Journal: Nihon yakurigaku zasshi. Folia pharmacologica Japonica

Published: March 01, 2026

Samelisant (SUVN-G3031), a histamine H3 receptor inverse agonist, as a potential treatment for narcolepsy: a phase-2 drug evaluation.

Samelisant (SUVN-G3031), a histamine H3 receptor inverse agonist, as a potential treatment for narcolepsy: a phase-2 drug evaluation.

Journal: Expert opinion on investigational drugs

Published: February 23, 2026

Narcolepsy with co-occurring epilepsy: diagnostic pitfalls and management strategy.

Narcolepsy with co-occurring epilepsy: diagnostic pitfalls and management strategy.

Journal: Therapeutic advances in neurological disorders

Published: February 02, 2026

Exploration of the therapeutic potential of the HRH3 histamine receptor in MECP2-related disorders.

Exploration of the therapeutic potential of the HRH3 histamine receptor in MECP2-related disorders.

Journal: Neuropharmacology

Published: January 06, 2026

Showing 1-12 of 244

Last Updated: 09/26/2026